Evidence map›Paper›PMID 30568229›Full record

ArticleModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2019

Reply to 'MUC4 staining in sarcomatoid carcinomas' by Berg et al.

Vishwa Jeet Amatya, Kei Kushitani, Amany Sayed Mawas, Yoshihiro Miyata, Morihito Okada, Takumi Kishimoto, Kouki Inai, Yukio Takeshima

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Vishwa Jeet AmatyaDepartment of Pathology, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.ORCID http://orcid.org/0000-0002-4986-2109
Kei KushitaniDepartment of Pathology, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
Amany Sayed MawasDepartment of Pathology, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
Yoshihiro MiyataDepartment of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
Morihito OkadaDepartment of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
Takumi KishimotoDepartment of Internal Medicine, Okayama Rosai Hospital, Okayama, Japan.
Kouki InaiDepartment of Pathology, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
Yukio TakeshimaDepartment of Pathology, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan. ykotake@hiroshima-u.ac.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CarcinomaMesotheliomaHumansMucin-4Staining and LabelingMUC4 protein, humanMucin-4

Identifiers

PMID30568229

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.